Reporting standards for percutaneous thermal ablation of renal cell carcinoma

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 10, 2006, Pages 1563-1570

  Clark, Timothy W I ^a,j   Millward, Steven F ^b   Gervais, Debra A ^c   Goldberg, S Nahum ^d   Grassi, Clement J ^e   Kinney, Thomas B ^g   Phillips, David A ^f   Sacks, David ^h   Cardella, John F ⁱ  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^f University of Massachusetts   (United States)

^g UCSD MEDICAL CENTER   (United States)

^h READING HOSPITAL AND MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j Society of Interventional Radiology   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; FOLLOW UP; HEMODYNAMICS; HUMAN; INTERVENTIONAL RADIOLOGY; KIDNEY CARCINOMA; MEDICAL DOCUMENTATION; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SELECTION; PERCUTANEOUS THERMAL ABLATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW; STANDARD; TREATMENT INDICATION; TUMOR BIOPSY;

EID: 33750054100     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000236718.12560.47     Document Type: Article

References (35)

1. American Cancer Society. Cancer Facts and Figures 2005. Atlanta: American Cancer Society, 2005. Available at: http://www.cancer.org/downloads/STT/ CancerFacts&Figures2005TM.pdf. Accessed January 15, 2006.
2. Levine E, Huntrakoon M, Wetzel LH. Small renal neoplasms: clinical, pathologic, and imaging features. AJR Am J Roentgenol 1989; 153:69-73.
3. Smith SJ, Bosniak MA, Megibow AJ, et al. Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989; 170:699-703.
4. Ozen H, Colowick A, Freiha FS. Incidentally discovered solid renal masses: what are they? Br J Urol 1993; 72:274-276.
5. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281:1628-1631.
6. Butler BP, Novick AC, Miller DP, et al. Management of small unilateral renal cell carcinomas: radical versus nephronsparing surgery. Urology 1995; 45:34-40.
7. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162:1930-1933.
8. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000; 163:442-445.
9. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167:10-15.
10. Hwang JJ, Walther MM, Pautler SE, et al. Radiofrequency ablation of small renal tumors: intermediate results. J Urol 2004; 171:1814-1818.
11. Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. J Vasc Interv Radiol 2005; 16:597-613.
12. Kidney. In: American Joint Committee on Cancer Staging Manual, 6th ed. New York: Springer, 2002;323-328.
13. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
14. Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217:665-672.
15. Mai KT, Alhalouly T, Lamba M, et al. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology. Diagn Cytopathol 2003; 28:66-70.
16. Crapanzano JP. Fine-needle aspiration of renal angiomyolipoma: cytological findings and diagnostic pitfalls in a series of five cases. Diagn Cytopathol 2005; 32:53-57.
17. Tuncali K, vanSonnenberg E, Shankar S, et al. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am J Roentgenol 2004; 183:575-582.
18. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: Saunders/Elsevier, 2005.
19. Cestari A, Guazzoni G, dell'Acqua V, et al. Laparoscopic cryoablation of solid renal masses: intermediate term followup. J Urol 2004; 172:1267-1270.
20. Castilla EA, Liou LS, Abrahams NA, et al. Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 2002; 60:993-997.
21. Goldberg SN, Charboneau JW, Dodd GD Jr, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345.
22. Gervais DA, Arellano RS, McGovern FJ, et al. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185:72-80.
23. Kam AW, Littrup PJ, Walther MM, et al. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol 2004; 15:753-758.
24. Ahrar K, Matin S, Wallace MJ, et al. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol 2005; 185:86-88.
25. Schultze D, Morris CS, Bhave AD, et al. Radiofrequency ablation of renal transitional cell carcinoma with protective cold saline infusion. J Vasc Interv Radiol 2003; 14:489-492.
26. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2005; 16:765-778.
27. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003; 180:1509-1513.
28. Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 2005; 235:1065-1071.
29. Gill IS, Remer EM, Hassan WA, et al. Renal cryoablation: outcome at 3 years. J Urol 2005; 173:1903-1907.
30. Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001; 166:825-830.
31. Safaei A, Figlin R, Hoh CK, et al. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002; 57:56-62.
32. Burke DR, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol 2003; 14(suppl): S243-S246.
33. Poulakis V, Witzsch U, de Vries R, et al. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery. Urology 2003; 62:814-820.
34. Shinohara N, Harabayashi T, Sato S, et al. Impact of nephron-sparing surgery on quality of life in patients with localized renal cell carcinoma. Eur Urol 2001; 39:114-119.
35. Bacik J, Mazumdar M, Murphy BA, et al. The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers. Qual Life Res 2004; 13:137-154.